Bioavailability Study of Doxycycline Monohydrate Capsules and Monodox Under Fasting and Fed Conditions

To Determine Bioequivalence Under Fed Conditions Clinical Trial

Official title:
Randomized, Open-Label, 3-Way Crossover, Comparative Bioavailability Study of Par's and Oclassen's (Monodox) Doxycycline Monohydrate Capsules Administered as 1 x 100 mg Capsule in Healthy Adult Males Under Fasting and Fed Conditions

Status Completed

Clinical Trial Summary

To compare the rate and extent of absorption of doxycycline monohydrate capsules equivalent to 100 mg doxycycline (Par) versus Monodox (Oclassen Pharmaceuticals)

Clinical Trial Description

To compare the rate and extent of absorption of doxycycline monohydrate capsules equivalent to 100 mg doxycycline by Par Pharmaceutical Inc., USA (test) versus Monodox by Oclassen Pharmaceuticals, Inc., USA (reference) administered as a 1 x 100 mg capsule under fasting and fed conditions. ;

Study Design

Related Conditions & MeSH terms

Disease
To Determine Bioequivalence Under Fed Conditions

Clinical Trial Details

NCT number	NCT00652704
Study type	Interventional
Source	Par Pharmaceutical, Inc.
Contact
Status	Completed
Phase	Phase 1
Start date	July 1999
Completion date	September 1999

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT00652600` - Bioavailability Study of Propranolol Under Fed Conditions	Phase 1
Completed	`NCT01380496` - Bioequivalence Study of Doxycycline Monohydrate Tablets Under Fed Conditions	Phase 1
Completed	`NCT00652821` - Bioavailability Study of Tramadol/APAP Tablets Under Fed Conditions	Phase 1
Completed	`NCT00652873` - Bioequivalence Study of Cabergoline Tablets and Dostinex Under Fed Conditions	Phase 1
Completed	`NCT00652730` - Bioavailability Study of (Buspar) Buspirone HCl Tablets Under Fasting and Fed Conditions	Phase 1
Completed	`NCT05337969` - The Study Aims to Show Bioequivalence of the Test Product and the Reference Reference Product in a Crossover Design Study Healthy Volunteers. Additionally, the Safety Profile of Test Product Compared to Reference Product Will be Assessed.	N/A
Completed	`NCT05329857` - The Study Intends to Show Bioequivalence of the Test Product and the Reference Reference Product in a Crossover Design Study Healthy Volunteers. Additionally, the Safety Profile of Test Product Compared to Reference Product Will be Evaluated.	N/A
Completed	`NCT00653003` - Bioavailability Study of Leflunomide Tablets Under Fed Conditions	Phase 1
Completed	`NCT01380431` - A Comparative Bioavailability Study of Lisinopril Tablets, 40 mg - Effect of Food Study	Phase 1